Dariohealth secures $50 million dollar non-dilutive credit facility with orbimed

Investment from elite healthcare fund provides validation, access to capital and significant runway to execute on strategic operating plan new york , june 9, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today it closed a senior secured term loan facility of up to $50 million with orbimed, a leading investor in the healthcare industry, providing non-dilutive capital to fund the continued development of its platform and the acceleration of its adoption in the multi-billion dollar global chronic disease management market.     the five-year, $50 million facility is structured with a $25 million loan at closing and an additional $25 million available for a future draw before june 30, 2023, subject to dario achieving certain revenue thresholds.
DRIO Ratings Summary
DRIO Quant Ranking